Latest Information Update: 23 Jan 2013
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.
If you are a subscriber to this content then contact us at
so we can help.